Company Filing History:
Years Active: 2017
Title: Ilhyang Kim: Innovator in Azaindole Derivatives
Introduction
Ilhyang Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective histone deacetylase (HDAC) inhibitors. His work focuses on novel azaindole derivatives that have the potential to treat various diseases.
Latest Patents
Ilhyang Kim holds a patent for "Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the same." This invention relates to novel azaindole derivatives that exhibit HDAC inhibitory activity. The patent covers isomers, pharmaceutically acceptable salts, hydrates, and solvates of these derivatives. The pharmaceutical compositions developed from these compounds can be used to treat malignant tumors, inflammatory diseases, rheumatoid arthritis, and neurodegenerative diseases. He has 1 patent to his name.
Career Highlights
Ilhyang Kim is associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His research has the potential to impact the treatment of serious health conditions, showcasing his commitment to advancing medical science.
Collaborations
Ilhyang Kim has collaborated with notable colleagues, including ChangSik Lee and Hyun-Mo Yang. These partnerships have contributed to the development of his innovative pharmaceutical solutions.
Conclusion
Ilhyang Kim's work in developing azaindole derivatives represents a significant advancement in the field of pharmaceuticals. His contributions have the potential to lead to new treatments for various diseases, highlighting the importance of innovation in healthcare.